TXMD

TherapeuticsMD Inc. Common Stock (TXMD)

Stock · NASDAQ · Health Care

$2.22as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$2.04
Industry
Biotechnology: Pharmaceutical Preparations

How TherapeuticsMD Inc. Common Stock Makes Money

Where the revenue actually goes — FY2024 annual results

market-wall.comTotalRevenue$1.76MSG&A$4.74M (269%)TXMD

Source: 10-K filed Mar 27, 2025 · via SEC EDGAR / Finnhub

TherapeuticsMD Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • TXMD
    TherapeuticsMD Inc. Common Stock
    $2.22
    ▼ 0.89%
    Market cap $23.61MP/E
  • CALC
    CalciMedica Inc. Common Stock
    $0.4644
    ▼ 1.19%
    Market cap $23.14MP/E
    $0.4606$7.2
  • LGVN
    Longeveron Inc. Class A Common Stock
    $6.72
    ▼ 1.47%
    Market cap $23.13MP/E
    $4.75$12.3
  • BRNS
    Barinthus Biotherapeutics plc American Depositary Shares
    $0.7464
    ▲ 2.11%
    Market cap $24.51MP/E
    $0.512$1.83
  • TVRD
    Tvardi Therapeutics Inc. Common Stock
    $1.8
    ▲ 0.00%
    Market cap $25.13MP/E
    $1.5$43.65
  • ACTU
    Actuate Therapeutics Inc. Common stock
    $1.67
    ▼ 1.18%
    Market cap $25.36MP/E
    $0.9$9.22
  • CLRB
    Cellectar Biosciences Inc. Common Stock
    $2.54
    ▲ 0.00%
    Market cap $21.26MP/E
    $2.2$6.52

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
3.90M
Total value held
$7.86M
Institutional holders
47
Top holders this quarter
  • Unknown1.19M
  • Unknown635.2K
  • Unknown420.4K
  • Unknown353.7K
  • Unknown345.9K
  • Unknown209.2K
  • Unknown146.2K
  • Unknown129.2K
  • Unknown115.1K
  • Unknown109.8K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.